WO2002063013A2 - Human acid phosphatase gene - Google Patents

Human acid phosphatase gene Download PDF

Info

Publication number
WO2002063013A2
WO2002063013A2 PCT/CA2002/000105 CA0200105W WO02063013A2 WO 2002063013 A2 WO2002063013 A2 WO 2002063013A2 CA 0200105 W CA0200105 W CA 0200105W WO 02063013 A2 WO02063013 A2 WO 02063013A2
Authority
WO
WIPO (PCT)
Prior art keywords
protein
nucleic acid
acpt
substance
acid sequence
Prior art date
Application number
PCT/CA2002/000105
Other languages
English (en)
French (fr)
Other versions
WO2002063013A3 (en
Inventor
Eleftherios P. Diamandis
Maria Diamandis
George Yousef
Original Assignee
Mount Sinai Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai Hospital filed Critical Mount Sinai Hospital
Priority to AU2002229440A priority Critical patent/AU2002229440A1/en
Publication of WO2002063013A2 publication Critical patent/WO2002063013A2/en
Publication of WO2002063013A3 publication Critical patent/WO2002063013A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
PCT/CA2002/000105 2001-02-02 2002-02-01 Human acid phosphatase gene WO2002063013A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002229440A AU2002229440A1 (en) 2001-02-02 2002-02-01 Human acid phosphatase gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26625301P 2001-02-02 2001-02-02
US60/266,253 2001-02-02

Publications (2)

Publication Number Publication Date
WO2002063013A2 true WO2002063013A2 (en) 2002-08-15
WO2002063013A3 WO2002063013A3 (en) 2003-04-10

Family

ID=23013809

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2002/000105 WO2002063013A2 (en) 2001-02-02 2002-02-01 Human acid phosphatase gene

Country Status (2)

Country Link
AU (1) AU2002229440A1 (pt-PT)
WO (1) WO2002063013A2 (pt-PT)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006051172A1 (en) * 2004-11-11 2006-05-18 Chempath Oy Method for testing a compound for a therapeutic effect and a diagnostic method
EP2167118A1 (en) * 2007-06-19 2010-03-31 Chempath OY Transmembrane prostatic acid phosphatase

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds
WO2002010363A2 (en) * 2000-07-28 2002-02-07 Incyte Genomics, Inc. Protein phosphatases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds
WO2002010363A2 (en) * 2000-07-28 2002-02-07 Incyte Genomics, Inc. Protein phosphatases

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [Online] EBI; 15 March 1998 (1998-03-15) NCI-CGAP: "ak37c02.s1 Soares_testis_NHT Homo sapiens cDNA clone IMAGE:1408130 3' similar to SW:PPAP_HUMAN P15309 PROSTATIC ACID PHOSPHATASE PRECURSOR; mRNA sequence." Database accession no. AA861388 XP002215450 cited in the application *
DATABASE EMBL [Online] EBI; 17 September 1999 (1999-09-17) DOE JOINT GENOME INSTITUTE STANDFORD HUMAN GENOME CENTER: "Homo sapiens chromosome 19 clone CTD-2568A17, complete sequence." Database accession no. AC010325 XP002215449 -& DATABASE GENBANK [Online] NIH; SV AC010325.4, 21 June 2000 (2000-06-21) DOE JOINT GENOME INSTITUTE: "Homo sapiens chromosome 19 clone CTD-2568A17, working draft sequence, 23 unordered pieces." Database accession no. AC010325 XP002215462 *
DATABASE GENSEQ [Online] 11 October 2001 (2001-10-11) DRMANAC ET AL.: "Novel human diagnostic protein #23339" retrieved from ABG23348 XP002215463 -& WO 01 75067 A (HYSEQ INC ; LIU CHENGHUA (US); TANG Y TOM (US); DRMANAC RODOJE T (US)) 11 October 2001 (2001-10-11) *
GEIER C ET AL: "STRUCTURE OF THE HUMAN LYSOSOMAL ACID PHOSPHATASE GENE" EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 183, 1989, pages 611-616, XP002906605 ISSN: 0014-2956 *
SHARIEF F S ET AL: "HUMAN PROSTATIC ACID PHOSPHATASE: CDNA CLONING, GENE MAPPING AND PROTEIN SEQUENCE HOMOLOGY WITH LYSOSOMAL ACID PHOSPHATASE" BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 160, no. 1, 14 April 1989 (1989-04-14), pages 79-86, XP002031414 ISSN: 0006-291X *
YOUSEF GEORGE M ET AL: "Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis." GENOMICS, vol. 74, no. 3, 15 June 2001 (2001-06-15), pages 385-395, XP002215448 ISSN: 0888-7543 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006051172A1 (en) * 2004-11-11 2006-05-18 Chempath Oy Method for testing a compound for a therapeutic effect and a diagnostic method
US7919671B2 (en) 2004-11-11 2011-04-05 Chempath Oy Method for testing a compound for a therapeutic effect and a diagnostic method
EP2167118A1 (en) * 2007-06-19 2010-03-31 Chempath OY Transmembrane prostatic acid phosphatase
EP2167118A4 (en) * 2007-06-19 2010-12-08 Chempath Oy TRANSMEMBRANE PROSTATIC ACID PHOSPHATASE

Also Published As

Publication number Publication date
AU2002229440A1 (en) 2002-08-19
WO2002063013A3 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
US7507403B2 (en) Kallikrein gene
JP3399539B2 (ja) 乳癌および卵巣癌の素因の診断方法
US20060134114A1 (en) Novel human kallikrein-like genes
US6566063B1 (en) Methods for determining metastatic potential of breast cancer cells by detecting GSEF gene product expression
AU2001287384A1 (en) Kallikrein gene
CA2284642A1 (en) Methods and compositions for diagnosis and treatment of breast cancer
WO2000053776A2 (en) Human kallikrein-like genes
JP2001511002A (ja) Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
US6593119B2 (en) Core 2 β-1,6-N-acetylglycosaminyltransferase gene
WO2002063013A2 (en) Human acid phosphatase gene
US20020110862A1 (en) Novel Siglec-like gene
US20030049651A1 (en) Tumor associated proteins
US6897052B1 (en) N-acetylglycosaminyl transferase genes
EP1724351A2 (en) Human Kallikrein-like genes
MXPA01001425A (es) Genes para n-acetilglicosaminil transferasa.
US20070077250A1 (en) Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene
KR20020013477A (ko) 염색체 17ｐ 연관된 전립선암 감수성 유전자
US20020081608A1 (en) Tumor associated proteins
WO2000069879A2 (en) Ca7 cg04 gene
CA2296936A1 (en) Novel core 2 beta-1,6-n-acetylglycosaminyltransferase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP